Search Results - "Monji, Keisuke"

Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study.

Authors: Ohba, Kojiro Monji, Keisuke Osawa, Takahiro et al.

Source: International Journal of Urology. Nov2023, Vol. 30 Issue 11, p977-984. 8p.

Current status and future perspective of immunotherapy for renal cell carcinoma.

Authors: Blas, Leandro Monji, Keisuke Mutaguchi, Jun et al.

Source: International Journal of Clinical Oncology. Aug2024, Vol. 29 Issue 8, p1105-1114. 10p.

Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan.

Authors: Anami, Toshiki Motoshima, Takanobu Matsushita, Yuto et al.

Source: International Journal of Clinical Oncology. Oct2025, Vol. 30 Issue 10, p2079-2086. 8p.

Fusion‐targeted biopsy significantly improves prostate cancer detection in biopsy‐naïve men.

Authors: Blas, Leandro Shiota, Masaki Tsukahara, Shigehiro et al.

Source: International Journal of Urology. Jul2023, Vol. 30 Issue 7, p600-604. 5p.

Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot‐assisted radical prostatectomy.

Authors: Lee, Ken Shiota, Masaki Takamatsu, Dai et al.

Source: International Journal of Urology. Apr2023, Vol. 30 Issue 4, p340-346. 7p.

Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer.

Authors: Kashiwagi, Eiji Shiota, Masaki Naganuma, Hidekazu et al.

Source: International Journal of Urology. Oct2022, Vol. 29 Issue 10, p1155-1162. 8p.

Impact of nerve sparing in robot‐assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrence.

Authors: Komori, Hiroki Blas, Leandro Shiota, Masaki et al.

Source: International Journal of Urology. Aug2022, Vol. 29 Issue 8, p824-829. 6p.

Validation of models predicting lymph node involvement probability in patients with prostate cancer.

Authors: Blas, Leandro Shiota, Masaki Nagakawa, Shohei et al.

Source: International Journal of Urology. May2022, Vol. 29 Issue 5, p428-434. 7p.

Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification.

Authors: Furukawa, Junya Kato, Taigo Yamasaki, Toshinari et al.

Source: International Journal of Clinical Oncology. Apr2025, Vol. 30 Issue 4, p749-760. 12p.

Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.

Authors: Yamashita, Takuya Shiota, Masaki Machidori, Asako et al.

Source: Cancer Investigation. Mar2021, Vol. 39 Issue 3, p251-256. 6p.

Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide.

Authors: Shiota, Masaki Machidori, Asako Abe, Tatsuro et al.

Source: International Journal of Urology. Dec2020, Vol. 27 Issue 12, p1109-1115. 7p.

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

Authors: Fujita, Kazutoshi Matsushita, Yuto Toyoda, Shingo et al.

Source: World Journal of Urology. 9/26/2024, Vol. 42 Issue 1, p1-8. 8p.

Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer.

Authors: Kashiwagi, Eiji Imada, Kenjiro Monji, Keisuke et al.

Source: Andrologia. Oct2019, Vol. 51 Issue 9, pN.PAG-N.PAG. 1p.

SY13-2 Current evidences in the first-line treatment of metastatic non-clear cell renal cell carcinoma.

Authors: Inokuchi, Junichi Goto, Shunsuke Monji, Keisuke et al.

Source: Annals of Oncology. 2023 Supplement 3, Vol. 34, pS1362-S1362. 1p.

Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticity.

Authors: Matsumoto, Takashi Uchiumi, Takeshi Monji, Keisuke et al.

Source: Oncogenesis. Nov2017, Vol. 6 Issue 11, p1-1. 1p.

Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.

Authors: Blas, Leandro Shiota, Masaki Takamatsu, Dai et al.

Source: World Journal of Urology. Jan2023, Vol. 41 Issue 1, p43-50. 8p.

Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.

Authors: Tomida, Ryotaro Takahashi, Masayuki Matsushita, Yuto et al.

Source: Clinical Genitourinary Cancer. Jun2024, Vol. 22 Issue 3, pN.PAG-N.PAG. 1p.

Melanin pigment interrupts the fluorescence staining of mitochondria in melanocytes.

Authors: Ando, Hideya Ohagi, Yoshiaki Yoshida, Moemi et al.

Source: Journal of Dermatological Science. Dec2016, Vol. 84 Issue 3, p349-351. 3p.

Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors.

Authors: Machidori, Asako Shiota, Masaki Kobayashi, Satoshi et al.

Source: Urologic Oncology. Jun2021, Vol. 39 Issue 6, p365.e1-365.e7. 1p.

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Authors: Takahashi M Matsushita Y Kojima T et al.

Corporate Authors: Takahashi M Matsushita Y Kojima T et al.

Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2025 Jun; Vol. 23 (3), pp. 102322. Date of Electronic Publication: 2025 Feb 26.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE